Time resolved and temperature dependence of the radiative properties of thiol-capped CdS nanoparticles films

In this work, we present the temperature-dependence and time-resolved photoluminescence (PL) of CdS nanoparticles capped independently with three different ligands thiophenol, thioglycerol, and l-cysteine over a broad temperature range from 10 to 300 K. The respective nanoparticles sizes in the three systems studied in this work are 1.5, 4, and 2 nm as determined from X-ray diffraction (XRD). From the analysis of AFM images, it was found that the lateral particle sizes of capped CdS nanoparticles are greater than those deduced from XRD or optical absorption measurements. The aim of this study is the investigation of the impact of the organic ligands on the radiative recombination dynamics in organically capped CdS nanoparticles. From the PL study and based on the temperature-dependence and time-resolved emission spectroscopy, we conclude that the emission of CdS QDs film originates from recombination of the delocalized carriers in the internal core states with a small contribution of the localized carriers at the interface. The PL decay reveals a biexponential behavior for the entire three samples at all temperatures. One of the two exponential components decays rapidly with a time τ(1) in the range 0.5–0.8 ns, whereas the other decays much more slowly, with a time τ(2) in the range 1–3 ns. The weak activation energy (32–37 meV) deduced from the temperature dependence of the PL intensity suggests the involvement of shallow traps. The analysis of the experimental results reveals a relatively narrow size distribution, an efficient surface passivation, and a satisfactory thermal stability of CdS nanocrystals

Effect of CdS nanocrystals on the photoluminescence of Eu3+-doped silicophosphate sol gel glass

In this work, we investigate the effect of co-doping with CdS nanoparticles on the photoluminescence properties of Eu3+ doped silicophosphate glass prepared via the sol gel method. Infrared spectroscopy (FTIR) revealed the insertion of phosphorus within the silicate network. XRD and TEM analyses revealed the presence of CdS nanoparticles dispersed in the glass matrix. Based on the optical study and the effective mass theory for spherical quantum dots, it was found that CdS nanocrystals have a gap of nearly 3.53 eV and a size of 2.42 nm. The enhancement of Eu3+ emission induced by CdS nanocrystals and thermal annealing was assigned to either an energy transfer via defect states or structural alteration of the glass network around the rare earth ions

Food processing and technology 1978: a summary of research

Evaluation of tomato cultivars for processing / W. A. Gould, W. Stone, J. Mount, L. Witt, Y. Yamada, and S. Z. Berry -- Geotrichum candidum in midwestern tomato processing plants and various methods of inhibiting its growth / James G. Fox and Wilbur A. Gould -- Effects of various qualities of raw tomatoes (subjective evaluation) on color of extractable juice (objective evaluation) / Yasunori Yamada and Wilbur A. Gould -- Protein content of seeds taken from tomatoes at various stages of ripeness / Daniel Brodowski and J. R. Geisman -- Effects of cultivar, break temperature, and extraction methods on the viscosity of tomato juice / Hashmy Bel-Haj and Wilbur A. Gould -- A study of some factors affecting the solid content of canned tomatoes / J. R. Mount and W. A. Gould -- Prediction of ascorbic acid stability in canned apple juice / Mohamed I. Mahmoud and Wilbur A. Gould -- Investigation of protein content of ohio grown soybeans / Girish N. Desai and Andrew C. Peng -- Recovery and functionality of soybean leaf proteins / Mohammed H. Ali and Andrew C. Peng -- Carotene content of green snap beans / H. Fenercioglu and D. E. Crean -- Effect of reconditioning on the ascorbic acid content of potato cultivars / I. S. Arkoudilos and D. E. Crean -- Kinetic studies of polyphenol oxidase from HiDri cabbage / Ling-May Chen and Andrew C. Peng -- Refinements in pickle brine recycling / T. Glares and J. R. Geisman -- Use of ultraviolet light to inhibit Staphylococcus aureus growth on the surface of baked pumpkin pie / Nicholas N. Kallas and Wilbur A. Gould -- Development of a nutritionally improved corn masa / Thomas H. Rieman and Wilbur A. Gould -- Mechanical deboning of Lake Erie freshwater drum / W. E. Stone and W. A. Gould -- Lake Erie freshwater drum fillet processing, storage, and evaluation / W. E. Stone and W. A. Goul

WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

Cutaneous leishmaniasis is due to a small parasite (Leishmania) that creates disfiguring sores, and affects more than one million persons (mainly children) each year. Treating lesions with a cream—instead of with injections as currently done—would greatly improve the well-being of affected patients. No cream formulation that would be efficient and would not create important skin irritation has been identified yet. Here, we tested a new cream formulation (WR279,396) containing paromomycin and gentamicin, two members of a well-known family of antibacterial antibiotics (aminoglycosides). Injectable paromomycin is efficient in other forms of the disease (visceral leishmaniasis). This was a carefully monitored study (phase 2) involving mainly children in Tunisia and France. The cream was applied twice a day for 20 days. The proportion of patients treated with the paromomycin-containing cream (active formulation) that cured (94%) was higher than that observed (71%) in patients treated with a cream that did not contain the active product (placebo formulation). Local irritation affected less than one-third of the patients and was usually mild. This new cream formulation was safe and effective in treating cutaneous leishmaniasis, thereby providing a new, simple, easily applicable, and inexpensive treatment for this neglected disease

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world's population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data. Methods: We estimated incidence and prevalence for 354 diseases and injuries and 3484 sequelae. We used an updated and extensive body of literature studies, survey data, surveillance data, inpatient admission records, outpatient visit records, and health insurance claims, and additionally used results from cause of death models to inform estimates using a total of 68 781 data sources. Newly available clinical data from India, Iran, Japan, Jordan, Nepal, China, Brazil, Norway, and Italy were incorporated, as well as updated claims data from the USA and new claims data from Taiwan (province of China) and Singapore. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, prevalence, remission, and cause of death for each condition. YLDs were estimated as the product of a prevalence estimate and a disability weight for health states of each mutually exclusive sequela, adjusted for comorbidity. We updated the Socio-demographic Index (SDI), a summary development indicator of income per capita, years of schooling, and total fertility rate. Additionally, we calculated differences between male and female YLDs to identify divergent trends across sexes. GBD 2017 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting. Findings: Globally, for females, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and haemoglobinopathies and haemolytic anaemias in both 1990 and 2017. For males, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and tuberculosis including latent tuberculosis infection in both 1990 and 2017. In terms of YLDs, low back pain, headache disorders, and dietary iron deficiency were the leading Level 3 causes of YLD counts in 1990, whereas low back pain, headache disorders, and depressive disorders were the leading causes in 2017 for both sexes combined. All-cause age-standardised YLD rates decreased by 3·9% (95% uncertainty interval [UI] 3·1–4·6) from 1990 to 2017; however, the all-age YLD rate increased by 7·2% (6·0–8·4) while the total sum of global YLDs increased from 562 million (421–723) to 853 million (642–1100). The increases for males and females were similar, with increases in all-age YLD rates of 7·9% (6·6–9·2) for males and 6·5% (5·4–7·7) for females. We found significant differences between males and females in terms of age-standardised prevalence estimates for multiple causes. The causes with the greatest relative differences between sexes in 2017 included substance use disorders (3018 cases [95% UI 2782–3252] per 100 000 in males vs s1400 [1279–1524] per 100 000 in females), transport injuries (3322 [3082–3583] vs 2336 [2154–2535]), and self-harm and interpersonal violence (3265 [2943–3630] vs 5643 [5057–6302]). Interpretation: Global all-cause age-standardised YLD rates have improved only slightly over a period spanning nearly three decades. However, the magnitude of the non-fatal disease burden has expanded globally, with increasing numbers of people who have a wide spectrum of conditions. A subset of conditions has remained globally pervasive since 1990, whereas other conditions have displayed more dynamic trends, with different ages, sexes, and geographies across the globe experiencing varying burdens and trends of health loss. This study emphasises how global improvements in premature mortality for select conditions have led to older populations with complex and potentially expensive diseases, yet also highlights global achievements in certain domains of disease and injury

Theoretical investigations of the IO,q+ (q = 2, 3, 4) multi-charged ions: Metastability,characterization and spectroscopy

International audienceUsing ab initio methodology, we studied the IOq+ (q = 2, 3, 4) multi-charged ions. Benchmarkcomputations on the IO(X2) neutral species allow validate the current procedure. For IO2+,several potential wells were found on the ground and the electronic excited states potentials withpotential barriers with respect to dissociation, where this dication can exist in the gas phase aslong-lived metastable molecules. We confirm hence the recent observation of the dication by massspectrometry. Moreover, we predict the existence of the metastable IO3+ trication, where a shallowpotential well along the IO internuclear distance is computed. This potential well supports morethan 10 vibrational levels. The IO3+ excited states are repulsive in nature, as well as the computedpotentials for the IO4+ tetracation. For the bound states, we give a set of spectroscopic parametersincluding excitation transition energies, equilibrium distances, harmonic and anharmonic vibrationalterms, and rotational constants. At the MRCI + Q/aug-cc-pV5Z(-PP) level, the adiabatic doubleand triple ionization energies of IO are computed to be ∼28.1 eV and ∼55.0 eV, respectively